Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 11.64% is 17% below its 5-year average of 14.00%, near the high end of its 5-year range (-99.51%–19.24%).
211.58% above its 12-month average of -10.43%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 17.05%.
GROSS MARGIN
11.64%
GROSS MARGIN AVG TTM
-10.43%
GROSS MARGIN AVG 3Y
14.34%
GROSS MARGIN AVG 5Y
14.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+211.58%
CURRENT VS 3Y AVG
-18.81%
CURRENT VS 5Y AVG
-16.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · INDUSTRIALS
26.94%
median of 434 covered companies
CURRENT VS SECTOR MEDIAN
-56.78%
vs the sector median at left
BioNexus Gene Lab Corp.
Market Cap
$3.00M
Gross Margin
11.64%
TTM Avg
-10.43%
3Y Avg
14.34%
5Y Avg
14.00%
Market Cap
$3.12M
Gross Margin
-50.06%
TTM Avg
-20.33%
3Y Avg
-5.72%
5Y Avg
-10.79%
Market Cap
$2.82M
Gross Margin
63.72%
TTM Avg
62.22%
3Y Avg
70.35%
5Y Avg
78.60%
Market Cap
$3.23M
Gross Margin
24.11%
TTM Avg
22.87%
3Y Avg
20.93%
5Y Avg
26.72%
Market Cap
$2.73M
Gross Margin
7.66%
TTM Avg
21.55%
3Y Avg
44.59%
5Y Avg
53.71%
Market Cap
$2.69M
Gross Margin
32.11%
TTM Avg
33.75%
3Y Avg
19.40%
5Y Avg
23.00%
Market Cap
$2.66M
Gross Margin
7.74%
TTM Avg
12.36%
3Y Avg
10.20%
5Y Avg
9.65%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioNexus Gene Lab Corp. (BGLC) | $3.00M | 11.64% | -10.43% | 14.34% | 14.00% |
| PTL Limited (PTLE)vs › | $2.97M | 1.27% | 0.79% | 1.24% | 1.24% |
| Polar Power, Inc. (POLA)vs › | $3.12M | -50.06% | -20.33% | -5.72% | -10.79% |
| Intelligent Group Limited (INTJ)vs › | $2.82M | 63.72% | 62.22% | 70.35% | 78.60% |
| Iveda Solutions, Inc. (IVDA)vs › | $3.23M | 24.11% | 22.87% | 20.93% | 26.72% |
| Top KingWin Ltd. Class A (DPU)vs › | $2.73M | 7.66% | 21.55% | 44.59% | 53.71% |
| DEFSEC Technologies Inc. (DFSC)vs › | $2.69M | 32.11% | 33.75% | 19.40% | 23.00% |
| Globavend Holdings Limited (GVH)vs › | $2.66M | 7.74% | 12.36% | 10.20% | 9.65% |
| YYForce Inc. (YFOR)vs › | $3.41M | N/A | N/A | N/A | N/A |
| Addentax Group Corp. (ATXG)vs › | $3.45M | 12.30% | 14.63% | 18.52% | 14.26% |
Gross Margin
11.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 17.05% |
| 2026-03-31 | -99.51% |
| 2025-12-31 | -0.82% |
| 2025-09-30 | 14.85% |
| 2025-06-30 | 16.28% |
| 2025-03-31 | 16.07% |
| 2024-12-31 | 12.25% |
| 2024-09-30 | 12.41% |
| 2024-06-30 | 14.62% |
| 2024-03-31 | 15.33% |
| 2023-12-31 | 11.73% |
| 2023-09-30 | 13.88% |
| 2023-06-30 | 13.23% |
| 2023-03-31 | 15.52% |
| 2022-12-31 | 11.95% |
| 2022-09-30 | 11.63% |
| 2022-06-30 | 9.79% |
| 2022-03-31 | 11.01% |
| 2021-12-31 | 14.04% |
| 2021-09-30 | 19.24% |
| 2021-06-30 | 15.12% |
| 2021-03-31 | 16.89% |
| 2020-12-31 | 15.28% |
| 2020-09-30 | 16.89% |
| 2020-06-30 | 14.43% |
| 2020-03-31 | 21.35% |
| 2019-12-31 | 64.70% |
| 2019-09-30 | 31.75% |
| 2019-06-30 | 21.37% |
| 2019-03-31 | 32.99% |
| 2018-12-31 | -71.49% |
| 2018-09-30 | 24.41% |
| 2018-06-30 | 23.05% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 85.67% |
